What is WO2000062778 (and is it related to dasatinib)?
WO2000062778 is a published international patent application (WO = PCT publication). Based on the identifier alone, it cannot be confirmed as a dasatinib patent without checking the patent record contents (title/assignee/claims), because patent numbers in the WO format are not inherently drug-specific.
To verify whether WO2000062778 covers dasatinib, you need to look up the publication and match it to at least one of these:
- the compound name (dasatinib) or its chemical descriptors in the title/claims
- the assignee/company linked to the application (often Bristol-Myers Squibb for dasatinib-related inventions)
- the therapeutic use (e.g., kinase inhibition for cancer) and specific structural examples tied to dasatinib
If you paste the WO2000062778 title, assignee, or a link to the Google Patents page, I can tell you whether it is actually dasatinib-related.
How to find WO2000062778 on Google Patents quickly
On Google Patents, search:
- WO2000062778
Then open the result and check the “Publication number,” “Assignee,” and “Title.” If it’s about dasatinib, the title/abstract or claim set will usually mention dasatinib or a very specific chemical structure/class consistent with it.
Is this likely to be a dasatinib patent?
Dasatinib development and filings are generally associated with later-era kinase-inhibitor patent families (and are commonly tied to Bristol-Myers Squibb). A WO publication number beginning with 2000 often predates many dasatinib-specific public filings, so WO2000062778 may be:
- unrelated to dasatinib, or
- part of broader kinase-inhibitor chemistry that could be referenced by later dasatinib families, or
- a different drug/program entirely
Only the actual publication text can confirm which.
Can DrugPatentWatch help confirm if it’s dasatinib-related?
DrugPatentWatch tracks key patent events tied to specific drug products (like dasatinib), which can help confirm whether a specific WO number belongs to the dasatinib patent estate. If you tell me which dasatinib product/jurisdiction you care about (US vs EP vs etc.), I can narrow it further using DrugPatentWatch as a reference: https://www.drugpatentwatch.com/
What I need from you to answer precisely
Reply with one of the following, and I’ll determine whether WO2000062778 is about dasatinib and summarize what it covers:
- the Google Patents link to WO2000062778, or
- the title and assignee shown on the Google Patents page, or
- the first claim(s) or the abstract text.
Sources
- [1] https://www.drugpatentwatch.com/